01 5Fosamax
Main Therapeutic Indication : Bone Health
Currency : USD
2015 Revenue in Millions : 470
2014 Revenue in Millions : 359
Growth (%) : -24%
Main Therapeutic Indication : Bone Health
Currency : USD
2014 Revenue in Millions : -16.10%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Bone Health
Currency : USD
2016 Revenue in Millions : 284
2015 Revenue in Millions : 359
Growth (%) : -21
Main Therapeutic Indication : Bone and Joint Diseases
Currency : USD
2017 Revenue in Millions : 241
2016 Revenue in Millions : 284
Growth (%) : -15
Main Therapeutic Indication : Bone And Joint Diseases
Currency : USD
2018 Revenue in Millions : 209
2017 Revenue in Millions : 241
Growth (%) : -13%
LOOKING FOR A SUPPLIER?